Read + Share
Amedeo Smart
Independent Medical Education
Li Q, Zhang K, Yu Y, Yu Z, et al. TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma. PLoS One 2024;19:e0310889.PMID: 39321199
Email
LinkedIn
Privacy Policy